Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Update

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the target of a significant growth in short interest in the month of July. As of July 31st, there was short interest totaling 4,200 shares, agrowthof4,100.0% from the July 15th total of 100 shares. Based on an average daily volume of 4,200 shares, the short-interest ratio is currently 1.0 days. Based on an average daily volume of 4,200 shares, the short-interest ratio is currently 1.0 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Price Performance

Shares of HROWM opened at $26.25 on Friday. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 12 month low of $24.90 and a 12 month high of $27.70. The stock’s 50 day moving average is $26.36 and its two-hundred day moving average is $26.42.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, July 31st. Investors of record on Tuesday, July 15th were given a dividend of $0.7422 per share. The ex-dividend date was Tuesday, July 15th. This is a positive change from Harrow Health, Inc. 11.875% Senior Notes due 2027’s previous quarterly dividend of $0.74. This represents a $2.97 dividend on an annualized basis and a yield of 11.3%.

About Harrow Health, Inc. 11.875% Senior Notes due 2027

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.